| AA | Arachidonic acid |
| AD | Alzheimer’s disease |
| ALX/FPR | Lipoxin A4/formyl peptide receptor |
| APP | Amyloid precursor protein |
| Aβ | Amyloid-beta |
| BBB | Blood-brain barrier |
| BLT | Leukotriene B4 receptor |
| ChemR | Chemerin receptor |
| CNS | Central nervous system |
| COX | Cyclooxygenase |
| CSF | Cerebrospinal fluid |
| DHA | docosahexaenoic |
| EPA | eicosapenraenoic |
| GPCR | G protein-coupled receptor |
| GPR | G protein receptor |
| LGR | Leucine-rich repeat containing G protein-coupled receptor |
| LT | Leukotriene |
| LOX | Lipoxygenase |
| LXA4 | Lipoxin A4 |
| MaR1 | Maresin 1 |
| MCI | Mild cognitive impairment |
| MMSE | Mini-Mental State Examination |
| MRI | Magnetic resonance imaging |
| NMDA | N-methyl-D-aspartate |
| NPD1 | Neuroprotectin D1 |
| NSAIDs | Non-steroidal anti-inflammatory drugs |
| PET | Positron emission tomography |
| PG | Prostaglandin |
| PPAR | Peroxisome proliferator-activated receptor |
| PUFA | Polyunsaturated fatty acid |
| RORα | Retinoic acid-related orphan receptor α |
| RvD1 | Resolvin D1 |
| RvE1 | Resolvin E1 |
| SPECT | Single photon emission computed tomography |
| SPM | Specialized pro-resolving lipid mediator |
| TX | Thromboxane |